MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medicalmpletes Acquisition of ZONARE Medical Systems STYLE="font-family:Times New Roman" SIZE="2"> Under thereement, Mindray has acquired ZONARE for a total purchase price of US$101.7 million insh,justed for workingpital at the closingte. Thempany expects that thembined business will benefit from ZONAREs strong innovative R&Dpability and directles and service network in the high-end ultrasound market together with]

MR [Mindray Medical International] 6-K: Mindray Medicalmpletes Acquisition of ZONARE Medical Systems STYLE=”font-family:Times

[Mindray Medicalmpletes Acquisition of ZONARE Medical Systems STYLE="font-family:Times New Roman" SIZE="2"> Under thereement, Mindray has acquired ZONARE for a total purchase price of US$101.7 million insh,justed for workingpital at the closingte. Thempany expects that thembined business will benefit from ZONAREs strong innovative R&Dpability and directles and service network in the high-end ultrasound market together with]

MR [Mindray Medical International] 6-K: Mindray Medicalmpletes Acquisition of ZONARE Medical Systems Under

[Mindray Medicalmpletes Acquisition of ZONARE Medical Systems Under thereement, Mindray has acquired ZONARE for a total purchase price of US$101.7 million insh,justed for workingpital at the closingte. Thempany expects that thembined business will benefit from ZONAREs strong innovative R&Dpability and directles and service network in the high-end ultrasound market together with Mindrays efficient engineering, extensive]

MR [Mindray Medical International] 6-K: Mindray to Acquire ZONARE Medical Systems SHENZHEN, China,

[Mindray to Acquire ZONARE Medical Systems SHENZHEN, China, June 12, 2013 – Mindray Medical International Limited (NYSE: MR), today announced a definitive agreement to acquire ZONARE Medical Systems, Inc. (ZONARE), an ultrasound technology leader in the high-end radiology segment for US$105 million. Mindray’s management expects the deal to strengthen its high-end ultrasound R&D and U.S. sales capabilities, furthering the company’s]

MR [Mindray Medical International] CORRESP: June 13, 2013 Ms. Kate Tillan Assistant Chief

[June 13, 2013 Ms. Kate Tillan Assistant Chief Accountant Division of Corporation Finance 100 F Street, NE Re: Mindray Medical International Limited Form 20-F for the Fiscal Year Ended December 31, 2012 Filed April 8, 2013 File No. 001-33036 Dear Ms. Tillan: MR Company Comment Letter 2012 Form 20-F Commission On behalf of Mindray Medical International Limited (“ Staff For]

Skip to toolbar